Stoke Therapeutics and Biogen in pact for treatment for severe form of childhood epilepsy

Stoke will receive $165 million upfront and may get up to $385 million in milestone payments.

Feb 18, 2025 - 14:50
 0
Stoke Therapeutics and Biogen in pact for treatment for severe form of childhood epilepsy
Stoke will receive $165 million upfront and may get up to $385 million in milestone payments.